← 返回专利悬崖列表
羟乙磺酸达尔西利
Tier C · 观察 / 贸易Dalpiciclib Isethionate
江苏恒瑞医药股份有限公司
原研
2021
首批上市
-
到期年(公开口径)
无销量数据
峰值销售
化学药
类型
靶点:CDK6、CDK4
商品名:艾瑞康
适应症(已批准):乳腺癌、转移性乳腺癌
各地区研发/上市状态
美国
-
欧盟
-
中国
批准上市
2021-12-31
日本
-
合成路线与中间体4 routes
原研路线 × 0优化路线(非专利)× 3工艺路线 × 1
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
优化Route 2步骤 8 · 总收率 261g(Dalpiciclib Isethionate-014)
Dalpiciclib Isethionate-0091016636-76-2Dalpiciclib Isethionate-0101637781-16-8Dalpiciclib Isethionate-011111-34-2Dalpiciclib Isethionate-0121637781-17-9Dalpiciclib Isethionate-0131980822-15-8Dalpiciclib Isethionate-0141980822-14-7Dalpiciclib Isethionate-0151637781-10-2Dalpiciclib Isethionate-0161637781-11-3Dalpiciclib Isethionate-017—Dalpiciclib Isethionate-01853939-30-3Dalpiciclib Isethionate-019286961-14-6Dalpiciclib Isethionate-020—API · 羟乙磺酸达尔西利
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| Dalpiciclib Isethionate-009 | 1016636-76-2在售 | 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7-one |
| Dalpiciclib Isethionate-010 | 1637781-16-8 | tert-Butyl 4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperidine-1-carboxylate |
| Dalpiciclib Isethionate-011 | 111-34-2在售 | 1-(Vinyloxy)butane |
| Dalpiciclib Isethionate-012 | 1637781-17-9 | tert-Butyl 4-(6-[[6-(1-butoxyethenyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl)piperidine-1-carboxylate |
| Dalpiciclib Isethionate-013 | 1980822-15-8 | tert-Butyl 4-[6-[(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperidine-1-carboxylate |
| Dalpiciclib Isethionate-014 | 1980822-14-7 | 2-Hydroxyethane-1-sulfonic acid 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperidin-4-yl)pyridin-2-yl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one |
| Dalpiciclib Isethionate-015 | 1637781-10-2 | 2-Amino-6-bromo-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
| Dalpiciclib Isethionate-016 | 1637781-11-3 | 2-Amino-6-(1-butoxyethenyl)-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
| Dalpiciclib Isethionate-017 | - | tert-Butyl 6-chloro-3',6'-dihydro[3,4'-bipyridine]-1'(2'H)-carboxylate |
| Dalpiciclib Isethionate-018 | 53939-30-3在售 | 5-Bromo-2-chloropyridine |
| Dalpiciclib Isethionate-019 | 286961-14-6 | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridine-1(2H)-carboxylate |
| Dalpiciclib Isethionate-020 | - | tert-Butyl 6-[[6-(1-butoxyethenyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]-3',6'-dihydro[3,4'-bipyridine]-1'(2'H)-carboxylate |
优化Route 3步骤 2 · 总收率 19.4g(Dalpiciclib Isethionate-008)
Dalpiciclib Isethionate-0081198408-35-3Dalpiciclib Isethionate-021—Dalpiciclib Isethionate-02279099-07-3Dalpiciclib Isethionate-023—API · 羟乙磺酸达尔西利
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| Dalpiciclib Isethionate-008 | 1198408-35-3 | tert-Butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate |
| Dalpiciclib Isethionate-021 | - | (9H-Fluoren-9-yl)methyl (5-bromopyridin-2-yl)carbamate |
| Dalpiciclib Isethionate-022 | 79099-07-3在售 | tert-Butyl 4-oxopiperidine-1-carboxylate |
| Dalpiciclib Isethionate-023 | - | tert-Butyl 4-[6-([[(9H-fluoren-9-yl)methoxy]carbonyl]amino)pyridin-3-yl]-4-hydroxypiperidine-1-carboxylate |
优化Route 4步骤 4 · 总收率 52g(Dalpiciclib Isethionate-008)
Dalpiciclib Isethionate-004228710-82-5Dalpiciclib Isethionate-0081198408-35-3Dalpiciclib Isethionate-024—Dalpiciclib Isethionate-025110-86-1Dalpiciclib Isethionate-026—Dalpiciclib Isethionate-027—API · 羟乙磺酸达尔西利
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| Dalpiciclib Isethionate-004 | 228710-82-5 | 5-Bromo-2-(2,5-dimethyl-1H-pyrrol-1-yl)pyridine |
| Dalpiciclib Isethionate-008 | 1198408-35-3 | tert-Butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate |
| Dalpiciclib Isethionate-024 | - | Chlorido[6-(2,5-dimethyl-1H-pyrrol-1-yl)pyridin-3-yl]magnesium |
| Dalpiciclib Isethionate-025 | 110-86-1 | Pyridine |
| Dalpiciclib Isethionate-026 | - | tert-Butyl 6-(2,5-dimethyl-1H-pyrrol-1-yl)[3,4'-bipyridine]-1'(4'H)-carboxylate |
| Dalpiciclib Isethionate-027 | - | tert-Butyl 4-[6-(2,5-dimethyl-1H-pyrrol-1-yl)pyridin-3-yl]piperidine-1-carboxylate |
工艺Route 1步骤 8 · 总收率 707g(Dalpiciclib Isethionate (Free))
Dalpiciclib Isethionate-0013612-20-2Dalpiciclib Isethionate-0021576-35-8Dalpiciclib Isethionate-00341780-52-3Dalpiciclib Isethionate-004228710-82-5Dalpiciclib Isethionate-0052348367-87-1Dalpiciclib Isethionate-0062348367-88-2Dalpiciclib Isethionate-0071159822-13-5Dalpiciclib Isethionate-0081198408-35-3Dalpiciclib Isethionate-0091016636-76-2Dalpiciclib Isethionate-0101637781-16-8API · 羟乙磺酸达尔西利
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| Dalpiciclib Isethionate-001 | 3612-20-2 | 1-Benzylpiperidin-4-one |
| Dalpiciclib Isethionate-002 | 1576-35-8 | 4-Methylbenzenesulfonhydrazide |
| Dalpiciclib Isethionate-003 | 41780-52-3 | N'-(1-Benzylpiperidin-4-ylidene)-4-methylbenzene-1-sulfonohydrazide |
| Dalpiciclib Isethionate-004 | 228710-82-5 | 5-Bromo-2-(2,5-dimethyl-1H-pyrrol-1-yl)pyridine |
| Dalpiciclib Isethionate-005 | 2348367-87-1 | 1'-Benzyl-6-(2,5-dimethyl-1H-pyrrol-1-yl)-1',2',3',6'-tetrahydro-3,4'-bipyridine |
| Dalpiciclib Isethionate-006 | 2348367-88-2 | 1'-Benzyl-1',2',3',6'-tetrahydro[3,4'-bipyridin]-6-amine |
| Dalpiciclib Isethionate-007 | 1159822-13-5 | 5-(Piperidin-4-yl)pyridin-2-amine |
| Dalpiciclib Isethionate-008 | 1198408-35-3 | tert-Butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate |
| Dalpiciclib Isethionate-009 | 1016636-76-2在售 | 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7-one |
| Dalpiciclib Isethionate-010 | 1637781-16-8 | tert-Butyl 4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperidine-1-carboxylate |
常见问题(FAQ)
羟乙磺酸达尔西利的适应症有哪些?
已批准的适应症包括:乳腺癌、转移性乳腺癌。
羟乙磺酸达尔西利的专利什么时候到期?
羟乙磺酸达尔西利的专利到期年暂无公开口径,本页会在数据管道核实后更新。
羟乙磺酸达尔西利有几条合成路线?
本站收录 4 条合成路线,最短路线 2 步、总收率 19.4g(Dalpiciclib Isethionate-008)。每条路线的中间体均带登记编号与 CAS 号。
羟乙磺酸达尔西利的关键中间体在哪里可以采购?
羟乙磺酸达尔西利的多条路线中间体已挂接 CAS 档案,其中 4 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。
如何获取羟乙磺酸达尔西利中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-10-22